| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/18/2007 | CN100998605A External application medicine for treating purulent zoster and its preparing method |
| 07/18/2007 | CN100998595A Medicine composition containing cefateram cyclodextrin capsule and its preparing method |
| 07/18/2007 | CN100998590A Injection containing Yanhuning and sodium chloride |
| 07/18/2007 | CN100998581A Injection liquid containing sodium decanoy acetaldehyde and sodium chloride |
| 07/18/2007 | CN100998575A Finger nail coating agent of antifungal agent and its preparing method |
| 07/17/2007 | US7244847 Bactericides |
| 07/17/2007 | US7244841 Porphyrin derivatives and their use in photodynamic therapy |
| 07/17/2007 | US7244819 Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244767 Therapy for multiple sclerosis, psoriasis, urticaria; antiarthritic agents; incotinence; antitumor, anticancer agents |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/17/2007 | US7244740 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| 07/17/2007 | US7244732 Prodrugs of heteroaryl compounds |
| 07/17/2007 | US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 07/17/2007 | US7244717 Mutagenic nucleoside analogs for the treatment of viral disease |
| 07/17/2007 | US7244716 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244706 For therapy of bacterial infections |
| 07/17/2007 | US7244705 Polyacid glycopeptide derivatives |
| 07/17/2007 | US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides |
| 07/17/2007 | US7244589 Chimeric immunogens |
| 07/17/2007 | US7244434 Expresses all structural proteins of a pestivirus (e.g., BVDV) except for a functional C protein; coding sequences for a signal sequence within the C protein essential for post translational processing are retained or replaced by a sequence for analogous signal sequences from another pestiviral species |
| 07/17/2007 | US7244424 Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic |
| 07/17/2007 | US7244418 For therapy of microbial infection of a nail plate |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2485834C Pseudopolymorphic forms of a hiv protease inhibitor |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/17/2007 | CA2347278C Vaccine based on attenuated haemophilus somnus |
| 07/17/2007 | CA2303389C Antimicrobial quinolones, their compositions and uses |
| 07/17/2007 | CA2285542C N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 07/17/2007 | CA2284501C Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates |
| 07/17/2007 | CA2216167C Glycopeptide antibiotic derivatives |
| 07/17/2007 | CA2172506C Mycophenolate mofetil and mycophenolic acid high dose oral suspensions |
| 07/17/2007 | CA2054438C Additives to feminine hygiene products |
| 07/12/2007 | WO2007079260A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 07/12/2007 | WO2007079086A1 Pyrazoloalkyl substituted imidazo ring compounds and methods |
| 07/12/2007 | WO2007077893A1 Therapeutic agent for liver disease and hepatic function-ameliorating agent |
| 07/12/2007 | WO2007077861A1 NF-κB INHIBITOR |
| 07/12/2007 | WO2007077806A1 Pharmaceutical composition for application to nail |
| 07/12/2007 | WO2007077573A1 Antimicrobial composition containing triclosan and at least one functionalized hydrocarbon |
| 07/12/2007 | WO2007077465A2 Treatment of hiv |
| 07/12/2007 | WO2007077454A2 A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 07/12/2007 | WO2007077278A1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus |
| 07/12/2007 | WO2007077203A2 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007077158A1 Pharmaceutical compositions for the eradication of helicobacter pylori |
| 07/12/2007 | WO2007062107A3 Immunostimulatory oligoribonucleotides |
| 07/12/2007 | WO2007060419A3 Method of preventing oral staining |
| 07/12/2007 | WO2007054279A8 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/12/2007 | WO2007051462A3 Use of tetraorganosilicon compounds |
| 07/12/2007 | WO2007041432A3 Cross-neutralization of hcv with recombinant proteins |
| 07/12/2007 | WO2007023507A3 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 07/12/2007 | WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections |
| 07/12/2007 | WO2007002308A3 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 07/12/2007 | WO2006130686A3 Hcv protease inhibitors in combination with food |
| 07/12/2007 | WO2006120576A3 Immunogens for meningitidis-a vaccines |
| 07/12/2007 | WO2006112717A3 Nutritional supplement for a category of hiv patients |
| 07/12/2007 | WO2006084131A3 Furin inhibitors and alpha-defensins for the treatment or prevention of papillomavirus infection |
| 07/12/2007 | WO2004112687A3 Antiviral acylguanidine compounds and methods |
| 07/12/2007 | US20070161692 Conformationally restricted polyamine analogs as disease therapies |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161667 Process for preparing inhibitors of nucleoside metabolism |
| 07/12/2007 | US20070161653 Pyrazolo-Pyridine Derivatives As Antiherpes Agents |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161634 Compounds as CCR5 antagonists |
| 07/12/2007 | US20070161630 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/12/2007 | US20070161602 Phosphonate compounds |
| 07/12/2007 | US20070161579 Nymphaeol-A, nymphaeol-B and nymphaeol-C; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement |
| 07/12/2007 | US20070161564 Methods for making Apo-2 ligand using divalent metal ions |
| 07/12/2007 | US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070160694 Preventives or remedies for tumor or human papillomaviral disease |
| 07/12/2007 | US20070160693 Extracts from fruit of Silybum marianum; root of Astragalus membranaceus var mongholicus or Hedysarum polybotrys; root of Salvia miltiorrhiza, Salvia bowleyana or Salvia przewalskii; fruit of Schisandra chinensis or Schisandra sphenanthera, inhibiting activity of causative Hepatitis C virus |
| 07/12/2007 | US20070160668 Prolonged release bioadhesive therapeutic systems |
| 07/12/2007 | US20070160631 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 07/12/2007 | US20070160630 Hepatitis-c virus 4, 5 and 6 |
| 07/12/2007 | US20070160607 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | DE102006002427A1 Neue Lysolipin Derivate New Lysolipin derivatives |
| 07/12/2007 | DE102005056513A1 Pharmaceutical active substance for the treatment of hepatitis A, hepatitis C, borrelia and/or multiple sclerosis, comprises an unpurified gland secretion obtained from animals of the class Diplopoda |
| 07/12/2007 | DE102005056194A1 Neue Lipopeptid Zusammensetzungen New lipopeptide compositions |
| 07/12/2007 | CA2847871A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 07/12/2007 | CA2671322A1 Compositions and methods for treating actin-mediated medical conditions by administering an actin modulating agent |
| 07/12/2007 | CA2638005A1 A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 07/12/2007 | CA2635994A1 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 07/12/2007 | CA2635992A1 Medicament for topical use |
| 07/12/2007 | CA2635986A1 Composition and method of use thereof |
| 07/12/2007 | CA2635468A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 07/12/2007 | CA2635396A1 Carbonates of fenicol antibiotics |
| 07/12/2007 | CA2635318A1 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 07/12/2007 | CA2634334A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |